| Oct 30 |
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
|
| Oct 29 |
Penumbra Q3 2024 Earnings Preview
|
| Oct 25 |
Key Takeaways From Penumbra Analyst Ratings
|
| Oct 23 |
Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Oct 15 |
Penumbra completes enrolment for THUNDER study to treat ischemic stroke
|
| Oct 14 |
Why Penumbra Stock Zoomed 4% Higher Today
|
| Oct 14 |
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
|
| Oct 9 |
Here's Why You Should Retain Penumbra Stock in Your Portfolio Now
|
| Oct 9 |
Penumbra price target raised to $222 from $205 at RBC Capital
|
| Oct 8 |
Critical Insights From Penumbra Analyst Ratings: What You Need To Know
|
